Projects per year
Organisation profile
Organisation profile
Department of Pathology established in Aug. 1961. The first department director was Prof. Ting-Yao Chen. Prof. Chen constructed the pathology teaching system for students of medicine, phamacology, medical technology, and nursing since. Aug. 1962. The pathology department also provided pathology services for hospital in addition to teaching for the college. After the retirement of Prof. Chen in 1997, Prof. Huang became the director of the department.
Fingerprint
Dive into the research topics where Department of Pathology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
I-Wei Chang
- Department of Pathology - Assistant Professor
- Taipei Municipal Wanfang Hospital - Visiting Staff
Person: Researcher
-
Wei-Chin Chang
- Department of Pathology - Assistant Professor
- Taipei Medical University Hospital - Visiting Staff
Person: Researcher
-
Bo-Jung Chen
- Department of Pathology - Assistant Professor
- Taipei Medical University Shuang Ho Hospital - Visiting Staff
Person: Researcher
-
Utilizing Glucosamine-Labeled Nanodrugs as a Novel Pancreatic Cancer Stem Cell Therapy to Counteract Metabolic Compensation and Synergistically Inhibit Transcriptional Activity( I )
Shen, Y.-A. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
科研創業計畫：癌幹細胞篩選技術平台暨細胞療法開發之商業化應用
Shen, Y.-A. (PI)
1/1/24 → 12/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Exploring the Mechanism and Clinical Significance of Egfr/Suclg2/Vegfa Driving the Neuroendocrine Differentiation of Prostate Cancer
Chen, W.-Y. (PI)
8/1/23 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
Research output
-
Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor
Chen, L. Y., Shen, Y. A., Chu, L. H., Su, P. H., Wang, H. C., Weng, Y. C., Lin, S. F., Wen, K. C., Liew, P. L. & Lai, H. C., Jun 2024, In: Antioxidants. 13, 6, 735.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Aneuploidy Landscape in Precursors of Ovarian Cancer
Wang, Y., Douville, C., Chien, Y.-W., Wang, B. G., Chen, C.-L., Pinto, A., Smith, S. A., Drapkin, R., Chui, M. H., Numan, T., Vang, R., Papadopoulos, N., Wang, T.-L., Shih, I.-M. & Chien, C., Feb 1 2024, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 30, 3, p. 600-615 16 p.Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus) -
An Infant-Type Hemispheric Glioma With SOX5::ALK: A Novel Fusion
Tsai, C. C., Huang, M. H., Fang, C. L., Hsieh, K. L. C., Hsieh, T. H., Ho, W. L., Chang, H., Tsai, M. L., Kao, Y. C., Miser, J. S., Su, M. Y., Wong, T. T. & Liu, Y. L., Feb 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 1Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
Datasets
-
Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.13352142.v1, https://springernature.figshare.com/articles/figure/Additional_file_1_of_Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/13352142/1
Dataset
-
Additional file 2: Figure S1. of Secretory RAB GTPase 3C modulates IL6-STAT3 pathway to promote colon cancer metastasis and is associated with poor prognosis
Chang, Y.-C. (Creator), Su, C.-Y. (Contributor), Chen, M.-H. (Creator), Chen, W.-S. (Creator), Chen, C.-L. (Creator) & Hsiao, M. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3845803_d2.v1, https://springernature.figshare.com/articles/figure/Additional_file_2_Figure_S1_of_Secretory_RAB_GTPase_3C_modulates_IL6-STAT3_pathway_to_promote_colon_cancer_metastasis_and_is_associated_with_poor_prognosis/5284762/1
Dataset
-
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
Lin, Y.-C. (Contributor), Wen, K.-C. (Creator), Sung, P.-L. (Contributor), Chou, Y.-T. (Creator), Liew, P.-L. (Contributor), Chen, L.-Y. (Contributor), Huang, R.-L. (Creator), Lai, H.-C. (Contributor) & Chang, L.-T. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5234313.v1, https://springernature.figshare.com/collections/Complete_remission_of_heavily_treated_ovarian_clear_cell_carcinoma_with_ARID1A_mutations_after_pembrolizumab_and_bevacizumab_combination_therapy_a_case_report/5234313/1
Dataset